Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.047 0.2
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.045 0.2
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.046 0.2
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.041 0.2
mRNA MLN4924 GDSC1000 pan-cancer AAC -0.051 0.2
mRNA Erlotinib gCSI pan-cancer AAC 0.072 0.2
mRNA PF-750 CTRPv2 pan-cancer AAC 0.05 0.2
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.043 0.2
mRNA COL-3 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA importazole CTRPv2 pan-cancer AAC 0.049 0.2
Download CSV